CONCORD BIOTECH
|
CONCORD BIOTECH Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹10 Cr | ₹10 Cr | ₹9.51 Cr | ₹9.51 Cr | ₹9.51 Cr |
Equity - Authorised | ₹11 Cr | ₹11 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr |
Equity - Issued | ₹10 Cr | ₹10 Cr | ₹9.51 Cr | ₹9.51 Cr | ₹9.51 Cr |
Equity Paid Up | ₹10 Cr | ₹10 Cr | ₹9.51 Cr | ₹9.51 Cr | ₹9.51 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹1,516 Cr | ₹1,280 Cr | ₹1,094 Cr | ₹990 Cr | ₹761 Cr |
Securities Premium | ₹82 Cr | ₹82 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹1,405 Cr | ₹1,168 Cr | ₹982 Cr | ₹878 Cr | ₹649 Cr |
General Reserves | ₹29 Cr | ₹29 Cr | ₹29 Cr | ₹29 Cr | ₹29 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹1,516 Cr | ₹1,280 Cr | ₹1,094 Cr | ₹990 Cr | ₹761 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,527 Cr | ₹1,290 Cr | ₹1,103 Cr | ₹999 Cr | ₹770 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | ₹6.24 Cr | ₹31 Cr | ₹56 Cr | ₹36 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹6.23 Cr | ₹31 Cr | ₹56 Cr | ₹81 Cr | ₹48 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-6.23 Cr | ₹-25 Cr | ₹-25 Cr | ₹-25 Cr | ₹-13 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹28 Cr | ₹23 Cr | ₹21 Cr | ₹17 Cr | ₹15 Cr |
Deferred Tax Assets | ₹2.45 Cr | ₹2.18 Cr | ₹1.95 Cr | ₹0.60 Cr | ₹0.59 Cr |
Deferred Tax Liability | ₹31 Cr | ₹26 Cr | ₹23 Cr | ₹18 Cr | ₹16 Cr |
Other Long Term Liabilities | ₹1.89 Cr | ₹0.16 Cr | ₹0.31 Cr | ₹1.63 Cr | ₹2.94 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.96 Cr | ₹2.30 Cr | ₹1.87 Cr | ₹2.10 Cr | ₹1.59 Cr |
Total Non-Current Liabilities | ₹32 Cr | ₹32 Cr | ₹54 Cr | ₹77 Cr | ₹55 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹94 Cr | ₹94 Cr | ₹83 Cr | ₹46 Cr | ₹71 Cr |
Sundry Creditors | ₹94 Cr | ₹94 Cr | ₹83 Cr | ₹46 Cr | ₹71 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹38 Cr | ₹62 Cr | ₹66 Cr | ₹54 Cr | ₹42 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹3.66 Cr | ₹1.56 Cr | ₹12 Cr | ₹2.82 Cr | ₹20 Cr |
Interest Accrued But Not Due | ₹0.10 Cr | ₹0.26 Cr | ₹0.36 Cr | ₹0.51 Cr | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹35 Cr | ₹60 Cr | ₹53 Cr | ₹50 Cr | ₹22 Cr |
Short Term Borrowings | - | - | ₹4.34 Cr | ₹5.10 Cr | - |
Secured ST Loans repayable on Demands | - | - | ₹4.34 Cr | ₹5.10 Cr | - |
Working Capital Loans- Sec | - | - | ₹4.34 Cr | ₹5.10 Cr | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | ₹-4.34 Cr | ₹-5.10 Cr | - |
Short Term Provisions | ₹9.40 Cr | ₹36 Cr | ₹191 Cr | ₹131 Cr | ₹110 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.49 Cr | ₹9.00 Cr | ₹189 Cr | ₹130 Cr | ₹110 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹3.90 Cr | ₹27 Cr | ₹1.75 Cr | ₹0.66 Cr | ₹0.28 Cr |
Total Current Liabilities | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr | ₹223 Cr |
Total Liabilities | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr | ₹1,049 Cr |
ASSETS | |||||
Gross Block | ₹828 Cr | ₹793 Cr | ₹720 Cr | ₹645 Cr | ₹311 Cr |
Less: Accumulated Depreciation | ₹253 Cr | ₹200 Cr | ₹147 Cr | ₹99 Cr | ₹72 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹575 Cr | ₹593 Cr | ₹573 Cr | ₹546 Cr | ₹240 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹211 Cr | ₹173 Cr | ₹74 Cr | ₹18 Cr | ₹141 Cr |
Non Current Investments | ₹2.06 Cr | ₹0.13 Cr | ₹0.26 Cr | ₹0.37 Cr | ₹0.82 Cr |
Long Term Investment | ₹2.06 Cr | ₹0.13 Cr | ₹0.26 Cr | ₹0.37 Cr | ₹0.82 Cr |
Quoted | - | ₹0.13 Cr | ₹0.26 Cr | - | - |
Unquoted | ₹2.06 Cr | - | - | ₹0.37 Cr | ₹0.82 Cr |
Long Term Loans & Advances | ₹13 Cr | ₹12 Cr | ₹221 Cr | ₹141 Cr | ₹128 Cr |
Other Non Current Assets | ₹2.81 Cr | ₹8.87 Cr | ₹0.82 Cr | ₹0.45 Cr | ₹0.67 Cr |
Total Non-Current Assets | ₹804 Cr | ₹786 Cr | ₹869 Cr | ₹706 Cr | ₹510 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹244 Cr | ₹137 Cr | ₹73 Cr | ₹141 Cr | ₹198 Cr |
Quoted | ₹244 Cr | ₹137 Cr | ₹73 Cr | ₹141 Cr | ₹198 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹208 Cr | ₹212 Cr | ₹195 Cr | ₹154 Cr | ₹111 Cr |
Raw Materials | ₹63 Cr | ₹80 Cr | ₹81 Cr | ₹65 Cr | ₹61 Cr |
Work-in Progress | ₹123 Cr | ₹113 Cr | ₹90 Cr | ₹68 Cr | ₹39 Cr |
Finished Goods | ₹2.41 Cr | ₹4.33 Cr | ₹5.99 Cr | ₹8.99 Cr | ₹4.38 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹3.87 Cr | ₹3.10 Cr | ₹1.21 Cr | ₹0.25 Cr | ₹0.44 Cr |
Other Inventory | ₹15 Cr | ₹11 Cr | ₹17 Cr | ₹11 Cr | ₹6.15 Cr |
Sundry Debtors | ₹350 Cr | ₹274 Cr | ₹232 Cr | ₹178 Cr | ₹184 Cr |
Debtors more than Six months | ₹23 Cr | ₹18 Cr | ₹10 Cr | ₹2.49 Cr | ₹17 Cr |
Debtors Others | ₹328 Cr | ₹256 Cr | ₹223 Cr | ₹176 Cr | ₹168 Cr |
Cash and Bank | ₹47 Cr | ₹43 Cr | ₹89 Cr | ₹61 Cr | ₹2.59 Cr |
Cash in hand | ₹0.03 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr |
Balances at Bank | ₹47 Cr | ₹43 Cr | ₹89 Cr | ₹61 Cr | ₹2.58 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹27 Cr | ₹46 Cr | ₹33 Cr | ₹40 Cr | ₹14 Cr |
Interest accrued on Investments | ₹1.23 Cr | ₹0.79 Cr | ₹2.12 Cr | ₹1.47 Cr | ₹0.05 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹7.33 Cr | ₹5.52 Cr | ₹4.76 Cr | ₹4.54 Cr | ₹4.02 Cr |
Other current_assets | ₹18 Cr | ₹39 Cr | ₹26 Cr | ₹34 Cr | ₹10 Cr |
Short Term Loans and Advances | ₹21 Cr | ₹16 Cr | ₹10 Cr | ₹34 Cr | ₹29 Cr |
Advances recoverable in cash or in kind | ₹7.72 Cr | ₹1.38 Cr | ₹2.59 Cr | ₹1.46 Cr | ₹1.55 Cr |
Advance income tax and TDS | - | - | - | - | ₹3.80 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹13 Cr | ₹14 Cr | ₹7.84 Cr | ₹32 Cr | ₹23 Cr |
Total Current Assets | ₹896 Cr | ₹728 Cr | ₹633 Cr | ₹607 Cr | ₹539 Cr |
Net Current Assets (Including Current Investments) | ₹754 Cr | ₹536 Cr | ₹288 Cr | ₹371 Cr | ₹315 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr | ₹1,049 Cr |
Contingent Liabilities | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr | ₹3.89 Cr |
Total Debt | ₹6.23 Cr | ₹31 Cr | ₹61 Cr | ₹86 Cr | ₹48 Cr |
Book Value | 145.93 | 123.31 | 1,159.94 | 1,050.75 | 809.87 |
Adjusted Book Value | 145.93 | 123.31 | 105.45 | 95.52 | 73.62 |
Compare Balance Sheet of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹19,858.3 Cr | 2.1% | -5.9% | 40% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹425,930.0 Cr | -1.4% | -7.1% | 48% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,524.0 Cr | 1.5% | -2.1% | 63% | Stock Analytics | |
CIPLA | ₹118,828.0 Cr | -3.5% | -5.2% | 18% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,290.0 Cr | -3.9% | -10.1% | 10.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,280.3 Cr | -0.3% | -7.3% | 52.2% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 2.1% |
-5.9% |
40% |
SENSEX | -2.4% |
-4.2% |
19.5% |
You may also like the below Video Courses